GLAXF GSK plc
Price Chart
Executive Summary
GSK plc disclosed routine open-market share repurchases totaling 1,248,271 ordinary shares between May 26-29, 2026, as part of its existing buyback program. The purchases were executed through a non-discretionary broker agreement at volume-weighted average prices ranging from 1,899.95 GBp to 1,932.82 GBp per share. This is a standard capital return disclosure with no material new information for traders.
Actionable Insight
This is a routine buyback disclosure with no new program authorization or change in pace. Monitor GSK's next quarterly filing for any update on buyback program size or duration. No immediate trading action warranted.
Key Facts
- GSK purchased 1,248,271 ordinary shares over four trading days (May 26-29, 2026) at VWAPs between 1,899.95 GBp and 1,932.82 GBp.
- Total shares bought since program start on May 11, 2026: 4,590,420 ordinary shares.
- Post-purchase, GSK holds 265,968,706 shares in treasury (6.57% of voting rights) and has 4,050,256,108 shares outstanding.
- Purchases were made under a non-discretionary agreement with Citigroup Global Markets Limited dated May 8, 2026.
Financial Impact
Approximately £23.9 million deployed in the reported week (1,248,271 shares × ~£19.15 average VWAP). Cumulative program spend since May 11: ~£88 million.
Risk Factors
- Buyback pace may slow if GSK prioritizes other capital allocation (M&A, R&D spend).
- No change to underlying business fundamentals — share price impact from buybacks is typically modest and gradual.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-005584 |
| Document: 0001654954-26-005584-index-headers.html | 0001654954-26-005584 |
| Document: 0001654954-26-005584-index.html | 0001654954-26-005584 |
| Document: 0001654954-26-005584.txt | 0001654954-26-005584 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
4d ago
|
6-K
| $23.54 awaiting T+5 | awaiting T+5 | — | $26.63 (+13.13%) |
|
Jun 9, 2026
5d ago
|
6-K
| $24.66 awaiting T+5 | awaiting T+5 | — | $26.63 (+7.99%) |
|
Jun 9, 2026
5d ago
|
6-K
| $24.66 awaiting T+5 | awaiting T+5 | — | $26.63 (+7.99%) |
|
Jun 1, 2026
13d ago
|
6-K
| $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $26.63 (+9.81%) |
|
Jun 1, 2026
13d ago
|
6-K
| $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $26.63 (+9.81%) |
|
May 28, 2026
17d ago
|
6-K
| $24.58 $24.66 | ▲ +0.33% | ▲ +0.01% | $26.63 (+8.34%) |
|
May 27, 2026
18d ago
|
6-K
| $25.57 $23.94 | ▼ −6.37% | ▼ −7.58% | $26.63 (+4.15%) |
|
May 26, 2026
19d ago
|
6-K
| $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $26.63 (+4.43%) |
|
May 26, 2026
19d ago
|
6-K
| $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $26.63 (+4.43%) |
|
May 22, 2026
23d ago
|
6-K
| $26.00 $24.25 | ▼ −6.73% | ▼ −8.39% | $26.63 (+2.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access